For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with improved long-term graft survival and overall survival, according to study data
Patients report feeling more energetic and less hungry, making it easier to adhere to a healthier lifestyle
we can either put a pause on the cycle until we are on medication OR we can accidentally mimic the restrictive phase of it
The current data has shown good safety profile and lowering of hepatosteatosis
The weekly injections are designed to be convenient, allowing patients to incorporate the treatment into their routine with minimal disruption
doi: 10.1007/s12325-021-01637-6 [DOI] [PMC free article] [PubMed] [Google Scholar] 86.Xia L, Shen T, Dong W, et al